Advisory Committee on Breast Cancer in Young Women (ACBCYW), 14945 [2020-05259]
Download as PDF
<![CDATA[
14945
Federal Register / Vol. 85, No. 51 / Monday, March 16, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondents
Form name
Subject Matter Experts ...................................
Focus Group/ Developmental Project Documents.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2020–05314 Filed 3–13–20; 8:45 am]
BILLING CODE 4163–18–P
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–05257 Filed 3–13–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE–20–003,
Research Grants for Preventing
Violence and Violence Related Injury;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—CE–20–
003, Research Grants for Preventing
Violence and Violence Related Injury;
April 1–2, 2020, 8:30 a.m.-5:00 p.m.,
EDT, in the original FRN.
Embassy Suites Buckhead, 3285
Peachtree Road NE, Atlanta, GA 30305,
which was published in the Federal
Register on February 11, 2020, Volume
85, Number 28, pages 7760–7761.
The meeting is being amended to
change to a virtual meeting. The
meeting is closed to the public.
lotter on DSKBCFDHB2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Kimberly Leeks, Ph.D., M.P.H.,
Scientific Review Official, NCIPC, CDC,
4770 Buford Highway NE, Building 106,
MS S106–9, Atlanta, Georgia 30341,
telephone (770) 488–6562; KLeeks@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
18:29 Mar 13, 2020
Jkt 250001
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Advisory Committee on Breast
Cancer in Young Women (ACBCYW).
This meeting is open to the public,
limited only by audio and web
conference lines (80 audio and web
conference lines are available). The
public is welcome to listen to the
meeting by accessing the teleconference
number 1–888–606–5944, and the
passcode is 8340472, (80 lines are
available). The web conference access is
https://adobeconnect.cdc.gov/
rwa641n3jrry/. Online Registration
Required: All ACBCYW meeting
participants must register for the
meeting online at least 5 business days
in advance at https://wwwdev.cdc.gov/
cancer/breast/what_cdc_is_doing/
conference.htm. Please complete all the
required fields before submitting your
registration and submit no later than
May 7, 2020.
DATES: The meeting will be held on May
13, 2020, from 8:00 a.m. to 1:00 p.m.,
EDT.
SUMMARY:
The teleconference access is
1–888–606–5944, and the passcode is
8340472. The web conference access is
https://adobeconnect.cdc.gov/
rwa641n3jrry/.
ADDRESSES:
PO 00000
Frm 00074
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
15
Average
burden per
response
(in hours)
1
1
FOR FURTHER INFORMATION CONTACT:
Jeremy McCallister, Designated Federal
Officer, National Center for Chronic
Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE, Mailstop S107–4, Atlanta, Georgia
30341; Telephone: (404) 639–7989, Fax:
(770) 488–4760; Email: acbcyw@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters To Be Considered: The agenda
will include discussions on current
topics related to breast cancer in young
women. These will include Mental/
Behavioral Health, Sexual Health,
Genetics and Genomics, and Provider
Engagement. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–05259 Filed 3–13–20; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Page 14945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05259]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Advisory Committee on Breast
Cancer in Young Women (ACBCYW). This meeting is open to the public,
limited only by audio and web conference lines (80 audio and web
conference lines are available). The public is welcome to listen to the
meeting by accessing the teleconference number 1-888-606-5944, and the
passcode is 8340472, (80 lines are available). The web conference
access is https://adobeconnect.cdc.gov/rwa641n3jrry/. Online
Registration Required: All ACBCYW meeting participants must register
for the meeting online at least 5 business days in advance at https://wwwdev.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. Please
complete all the required fields before submitting your registration
and submit no later than May 7, 2020.
DATES: The meeting will be held on May 13, 2020, from 8:00 a.m. to 1:00
p.m., EDT.
ADDRESSES: The teleconference access is 1-888-606-5944, and the
passcode is 8340472. The web conference access is https://adobeconnect.cdc.gov/rwa641n3jrry/.
FOR FURTHER INFORMATION CONTACT: Jeremy McCallister, Designated Federal
Officer, National Center for Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway NE, Mailstop S107-4, Atlanta,
Georgia 30341; Telephone: (404) 639-7989, Fax: (770) 488-4760; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters To Be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05259 Filed 3-13-20; 8:45 am]
BILLING CODE 4163-18-P
